Orthopaedic implant coatings show promise but lack proof of broad clinical benefit, review finds

Coatings on metallic orthopaedic implants can change how the device surface behaves in the body, but an integrative review published in Frontiers in Medical Engineering concludes that their clinical value still depends on biological safety and function during service. The review, written by a single author at the Universidade Federal de Itajubá in Brazil, examines bone-facing arthroplasty interfaces and internal fracture fixation, connecting infection control and bone integration to corrosion, wear and coating integrity across titanium, stainless steel, cobalt–chromium and magnesium substrates. Its central message is deliberately cautious: experimental studies support biological activity under specific conditions, yet long-term knee comparisons and registry analyses do not demonstrate a general clinical advantage from coating alone.

The evidence base behind that judgement is narrower than the topic might suggest. The original corpus consisted of supplied bibliographic exports and targeted additions rather than a comprehensive, reproducible search. After two unavailable full texts were excluded, the review retained 27 primary reports. The sole author verified the animal judgements, and the laboratory appraisal used descriptive criteria; independent dual appraisal was not performed. The author supplements this retained denominator with additional published clinical, retrieval and mechanistic literature, which broadens the synthesis but also means the conclusions rest on a heterogeneous and partly non-systematic body of work.

Within that body of work, the strongest clinical signal comes from randomised trials of antibiotic-loaded hydrogel coatings, which provide evidence for early infection prevention in defined settings. Infection remains one of the most serious threats to joint replacement and fracture fixation, and a coating that delivers antimicrobial agents at the implant interface addresses the problem at the site where bacteria first colonise. The review treats this as the clearest example of a coating technology that has moved beyond the laboratory into controlled human testing, while stressing that the benefit is demonstrated for early outcomes in specific contexts rather than as a universal property of coated implants.

Elsewhere the picture is less decisive. Long-term comparisons in knee arthroplasty and analyses of registry data do not show that coatings, by themselves, produce a general clinical advantage. This matters because many coating technologies perform impressively in cell culture or animal models yet fail to translate into measurable differences in revision rates, function or implant survival over years of service. The review links this gap to the physical environment of the implant: corrosion, wear and the mechanical integrity of the coating all act on the same interface that must simultaneously fight infection and support bone integration.

Magnesium-based implants receive particular attention because they behave fundamentally differently from permanent metal hardware. Magnesium degrades in the body, so the review argues that assessment must be time-matched: degradation, residual mechanical support and healing have to be evaluated at the same time points, because a surface that supports bone early may lose structural role as it dissolves. Treating magnesium like titanium or stainless steel, with fixed endpoints unrelated to its degradation timeline, would misrepresent both its risks and its benefits.

Across coating families, the review finds that heterogeneity in composition, implant role, exposure and outcomes prevents any defensible ranking. A hydroxyapatite-like ceramic on a hip stem, an antibiotic hydrogel on a knee prosthesis and a degradable magnesium surface on a fracture plate face different mechanical loads, infection risks and biological demands. The author concludes that no single family can currently be declared superior on the available evidence, a conclusion reinforced by the limited ascertainment and single-reviewer appraisal that restrict the review’s own conclusions.

What the review does offer is a framework rather than a verdict. It proposes that a candidate antimicrobial exposure range must preserve host-cell function and integration on the same finished surface, meaning that any dose or chemistry that kills bacteria must be shown not to harm the osteoblasts and other host cells that must colonise that identical surface. Persistence of the antimicrobial effect after sterilisation, ageing and mechanical damage requires separate evaluation, because a coating that loses activity during handling or in service offers little protection at the moment of highest contamination risk.

The framework also demands concurrent assessment of function and device-specific durability. A coating is not judged only by how well cells attach to it in a dish, but by whether it maintains its biological performance while the implant corrodes, wears and bears load over its intended lifetime. This dual requirement, the review argues, is what separates a laboratory success from a clinically useful device, and it explains why laboratory activity alone cannot establish clinical benefit.

The review’s limitations are stated plainly in its own abstract. Limited ascertainment of studies and single-reviewer appraisal restrict the conclusions, and the retained corpus of 27 primary reports was not assembled through a reproducible search strategy. Readers should therefore treat the synthesis as a structured map of the field rather than a definitive comparative evaluation. The work was received on 8 October 2026 and accepted on 23 October 2026, and the author declares the claims as those of the author alone, not necessarily of the affiliated organisation or publisher.

For clinicians and researchers, the practical takeaway is that coatings remain a promising but unproven route to better implant outcomes outside the specific settings where randomised evidence exists. The review’s contribution is a checklist for future work: demonstrate antimicrobial activity within a range that preserves host-cell function on the same finished surface, verify persistence after sterilisation, ageing and mechanical damage, and for magnesium align every assessment with the degradation timeline. Until those standards are met across coating families, the field’s impressive laboratory results will continue to outrun its clinical evidence.

Subject of Research: An integrative review of surface engineering and coatings for metallic orthopaedic implants, linking infection control and bone integration to coating performance and clinical translation.

Article Title: Surface engineering and coatings for metallic orthopaedic implants: an integrative review of biological performance and clinical translation

Article References: Perez Teixeira, R. L. (2026). Surface engineering and coatings for metallic orthopaedic implants: an integrative review of biological performance and clinical translation. Frontiers in Medical Engineering, 4, Article 2022794. https://doi.org/10.3389/fmede.2026.2022794

Image Credits: AI Generated

DOI: 10.3389/fmede.2026.2022794

Keywords: orthopaedic implants, coatings, osseointegration, implant infection, corrosion, magnesium, surface engineering, clinical translation, arthritis, antimicrobial coatings, Surface, engineering